Mirabegron nighttime versus daytime dosing for women with overactive bladder syndrome: a randomized controlled trial
Abstract The effect of nighttime dosing versus daytime dosing of mirabegron is undetermined. Thus, this study aimed to clarify the effect of nighttime versus daytime mirabegron dosing. Between August 2017 and August 2023, all women with overactive bladder syndrome were randomly assigned to receive m...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-15780-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|